This message was sent to ##Email##
|
|
|
|
|
Nature via Medical Xpress
A trio of concerned scientists is issuing a warning regarding use of the phrase "mesenchymal stem cells." They claim the phrase is no longer useful because it encompasses too many cell types and because it has come to be associated with unproven medical applications.
READ MORE
HealthCanal.com
An MRI scan often generates an ocean of data, most of which is never used. When overlooked data is analyzed using a new technique developed at Washington University School of Medicine in St. Louis, they surprisingly reveal how many and which brain cells are present — and show where cells have been lost through injury or disease.
READ MORE
|
|
University of California, Irvine via Lab Manager
A team of researchers including University of California, Irvine, project scientist Rachita Sumbria, Ph.D., and UCI neurologist Dr. Mark J. Fisher have provided, for the first time, evidence that blood deposits in the brain may not require a blood vessel tear. The researchers found that brain endothelial cells, the cells that line blood vessels of the brain, have the capacity for engulfing red blood cells and depositing them outside the blood vessels and into the substance of the brain, without requiring a disruption of the vasculature.
READ MORE
|
Promoted by
|
|
|
|
 |
HealthDay News via CBS News
Tuberculosis remains the most lethal of infectious diseases worldwide, killing more than 1.6 million people a year. But researchers say a new vaccine might prevent half of full-blown illnesses in infected people who receive the shot.
READ MORE
DARK Daily
Anatomic pathologists and clinical laboratories know that biopsy samples are necessary to diagnose many diseases. But, current endoscopic imaging techniques used by physicians sometimes fail to clearly visualize disease sites.
READ MORE
 |
|
Discover YES. With LGC Maine Standards’ Yearly Evaluation Subscription program featuring VALIDATE®, you’ll never worry about challenging your instrument’s full Analytical Measurement Range (AMR). VALIDATE® offers multiple product configurations meeting the needs of the many instrument systems available, virtually eliminating dilutions while maximizing reportable ranges. Visit www.mainestandards.com or call 1-800-377-9684 to learn more. |
|
Medical News Today
Pancreatic ductal adenocarcinoma, a common and aggressive type of cancer, often develops resistance to treatments such as chemotherapy. However, a new drug tested in mice may be able to eliminate the cancer's defenses.
READ MORE
|
|
Wellcome Trust Sanger Institute via ScienceDaily
Genetic causes of rare neurodevelopmental disorders vary more than previously thought, a new study finds. Researchers discovered that serious rare disorders can be affected by combinations of common genetic variants, rather than solely individual genes.
READ MORE
ContagionLive
Despite big advances in the field of HIV treatment, including streamlined drug regimens that help infected individuals achieve normal or near-normal life spans, living with HIV often means dealing with neurocognitive impairment of some kind. This is particularly problematic in resource-limited settings such as parts of Africa, Asia and Latin America.
READ MORE
|
|
University of Colorado Boulder via Infection Control Today
With antibiotic-resistant “superbugs” now infecting 2 million people per year and a dearth of new medications in the pipeline to treat them, University of Colorado Boulder researchers are taking a novel approach to addressing the looming public health crisis: They’re helping develop new drugs to make old drugs work better. “We believe the compounds we’ve discovered have the potential to rejuvenate existing antibiotics — to make bacteria that are now insensitive to multiple drugs sensitive again,” said Corrie Detweiler, a professor of molecular, cellular and developmental biology who recently outlined her discovery in the journal PLOS Pathogens.
READ MORE
|
Is regenerative medicine the next big thing in Hematology testing?
Learn More
|
|
|
|
SeraSub® is a synthetic serum for use as a component in preparing standards and controls for in-vitro diagnostic tests. Learn more
|
|
|
|
HealthDay News
A combination of two HIV-fighting antibodies can suppress the virus in some patients, even after they stop standard drugs, a preliminary trial has shown.
Researchers found that among 11 HIV patients given the antibody combo, nine maintained complete suppression of the virus after going off their medication regimen. The benefit typically lasted about five months.
READ MORE
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
